A Survey of Physician and Molecular Tumor Board Perspectives on the Clinical Utility and Usability of Cellworks Singula™ and Ventura™ Reports in Facilitating Patient Treatment Decisions for Pan-Cancer Patients

RecruitingOBSERVATIONAL

Enrollment

730

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Pan-cancer

Interventions

OTHER

Cellworks Singula and Ventura reports

Personalized drug match reports based on patients' genomic aberration.

Trial Locations (1)

RECRUITING

Avera McKennan, Sioux Falls

All Listed Sponsors

collaborator

Cellworks Group Inc.

INDUSTRY

lead

Avera McKennan Hospital & University Health Center

OTHER